On review of systems, the patient reports slow progression of exertional dyspnea, fatigue, anorexia and hemoptysis times several weeks.
The patient was started on Solu-Medrol which was subsequently changed to Prednisone.
The patient was sent to [**Hospital1 190**] for emergent XRT and then sent back to [**Hospital3 1196**] for chemotherapy.
The patient received one cycle of Carboplatin and Taxol on [**2148-3-24**], and has had a total of five cycles of XRT (last cycle on [**2148-3-22**]).
The patient reportedly developed increasing cough with periods of bronchospasm and cyanosis despite increasing doses of steroids, nebulizer treatments and heated face mask.
Severe peripheral vascular disease on Coumadin status post bilateral femoral-popliteal bypass in [**2127**].
In [**2140**], the patient underwent a redo right axillary shunt to lower extremity bypass which was complicated by postoperative pulmonary embolus treated with Coumadin and IVC filter placement.
Coumadin 2 mg p.o.
Diltiazem 60 mg p.o.
Albuterol and Atrovent nebulizers q. four hours.
Decadron 4 mg intravenous q. four hours.
Levaquin 250 mg p.o.
Robitussin and Tessalon Pearls p.r.n.
On hospital day one, the patient underwent a rigid bronchoscopy with findings of the right upper lobe occluded by tumor; in addition, distal trachea had a near total obstruction by tumor.
The patient underwent placement of a stent to the distal trachea and right main stem bronchus.
Post-procedure, the patient maintained O2 saturations of 93 to 98% on a 50% face mask (this was her O2 requirement on admission).
The patient was continued on humidified oxygen, standing Albuterol and Atrovent nebulizers q. four hours.
In addition, the patient was given Lidocaine nebulizers to help with continued cough.
In addition, the patient was continued on Decadron to help decrease inflammation in the bronchus and was continued on prophylactic antibiotics with Levaquin and Flagyl post-procedure.
Diltiazem 60 mg p.o.
Heparin 5000 units subcutaneously twice a day.
Decadron 4 mg intravenously q. four hours.
Protonix 40 mg p.o.
Levaquin 500 mg p.o.
Flagyl 500 mg p.o.
Albuterol and Atrovent nebulizers q. eight hours.
Lidocaine nebulizers 2.5 cc.
Non-small cell lung cancer with compression of trachea and main stem bronchus status post stent placement.
